Entity
Description
  • Value proposition

    Biology x AI-powered drug development platform to transform precision oncology.

    Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

Corporate interactions BETA
Corporate TypeTweets Articles
Future4Care
Future4Care
Startup accelerator & VC
Future4Care
Startup accelerator & VC
Other

10 Dec 2024


Maddyness
Maddyness
Media, Media Production
Maddyness
Media, Media Production
Other

3 Dec 2024


Gouvernement Gouvernement
Other

20 Sep 2024


Ministère de la Santé Ministère de la Santé
Other

20 Sep 2024


Ministère de l'Enseignement supérieur et de la Recherche Ministère de l'Enseignement supérieur et de la Recherche
Government Administration
Other

20 Sep 2024


Ministry of Economy
Ministry of Economy
Government Administration
Ministry of Economy
Government Administration
Other

20 Sep 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

20 Sep 2024


ADEME
ADEME
National and local authorities, Environmental Services
ADEME
National and local authorities, Environmental Services
Other

20 Sep 2024


Direction Générale des Entreprises
Direction Générale des Entreprises
National and local authorities, Government Administration
Direction Générale des Entreprises
National and local authorities, Government Administration
Other

20 Sep 2024


Elaia
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

18 Jun 2024


Similar entities
Loading...
Loading...
Social network dynamics